Metformin Ameliorates Hepatic Steatosis Induced by Olanzapine through Inhibiting LXRα/PCSK9 Pathway

Researchers investigated the role of proprotein convertase subtilisin kexin type 9 (PCSK9) and explored the therapeutic effect of metformin for olanzapine-associated non-alcoholic fatty liver disease.